| 2026 |
Li, L. X., Hopkins, A. M., Woodman, R., Abuhelwa, A. Y., Gao, Y., Parent, N., . . . Sorich, M. J. (2026). Discrimination, calibration, and variable importance in statistical and machine learning models for predicting overall survival in advanced non–small cell lung cancer patients treated with immune checkpoint inhibitors. Journal of Clinical Epidemiology, 190, 11 pages.
DOI |
| 2026 |
Gao, Y., Li, L. X., Rowland, A., Karapetis, C. S., Parent, N., Kichenadasse, G., . . . Sorich, M. J. (2026). Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer. Cancer Letters, 639, 4 pages.
DOI |
| 2025 |
Gao, Y., Laka, M., & Merlin, T. (2025). Does regulatory and reimbursement parallel processing provide swifter funded access to medicines for patients? Evaluation of cancer medicines using the Australian parallel process. Value in Health, 28(3), 431-440.
DOI Scopus1 WoS1 |
| 2025 |
Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Ruanglertboon, W., Vitry, A., Gao, Y., . . . Hopkins, A. M. (2025). Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models. European Journal of Cancer, 218, 115274-1-115274-6.
DOI Scopus19 WoS16 Europe PMC13 |
| 2025 |
Gao, Y., Cheng, A., Li, L. X., Parent, N., Kichenadasse, G., Karapetis, C. S., . . . Sorich, M. J. (2025). Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial. International Journal of Cancer, 157(2), 336-344.
DOI Europe PMC1 |
| 2025 |
Carter, D., HASSAN, M., Gao, Y., Choi, O., Tamblyn, D., & Merlin, T. (2025). Engaging stakeholders along health technology assessment pathways: A scoping review of international practice. International Journal of Technology Assessment in Health Care, 41(1), e69-1-e69-9.
DOI |
| 2023 |
Gao, Y., Laka, M., & Merlin, T. (2023). Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia. International Journal of Technology Assessment in Health Care, 39(1), e28-1-e28-9.
DOI Scopus5 WoS5 Europe PMC5 |
| 2023 |
Gao, Y., Laka, M., & Merlin, T. (2023). OP71 Road To Public Funding Of Cancer Codependent Technologies In Australia In The Last Ten Years. International Journal of Technology Assessment in Health Care, 39(S1), S19.
DOI |
| 2021 |
Gao, Y., Ju, X., & Jamieson, L. (2021). Associations between dental care approachability and dental attendance among women pregnant with an Indigenous child: a cross-sectional study. BMC Oral Health, 21(1), 451-1-451-10.
DOI Scopus4 WoS3 Europe PMC3 |
